TB500
CAS No. 885340-08-9
TB500( —— )
Catalog No. M30027 CAS No. 885340-08-9
TB-500 is a synthesised peptide, essentially a short-chain version of the naturally occurring Thymosin Beta-4.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 32 | In Stock |
|
| 5MG | 52 | In Stock |
|
| 10MG | 86 | In Stock |
|
| 25MG | 155 | In Stock |
|
| 50MG | 226 | In Stock |
|
| 100MG | 334 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTB500
-
NoteResearch use only, not for human use.
-
Brief DescriptionTB-500 is a synthesised peptide, essentially a short-chain version of the naturally occurring Thymosin Beta-4.
-
DescriptionTB-500 is a synthesised peptide, essentially a short-chain version of the naturally occurring Thymosin Beta-4.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number885340-08-9
-
Formula Weight889.01
-
Molecular FormulaC38H68N10O14
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 250 mg/mL (281.21 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Randaiol
Randaiol is a natural product from Magnolia hypoleuca.
-
Bullatine B
Bullatine B shows analgesic/anti-inflammatory properties.
-
Ensituximab
Ensituximab (NEO-102) is a quasi-selective IgG1 monoclonal antibody against the MUC5AC variant with anti-tumour activity that inhibits colorectal and pancreatic cancer.
Cart
sales@molnova.com